Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | POLB | P06746 | 3/20 | 0.47 |
| ▸ | APAF1 | O14727 | 1/20 | 0.47 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.43 |
| ▸ | CA12 | O43570 | 1/20 | 0.43 |
| ▸ | CA1 | P00915 | 1/20 | 0.43 |
| ▸ | CA2 | P00918 | 1/20 | 0.43 |
| ▸ | CA9 | Q16790 | 1/20 | 0.43 |
| ▸ | CYP1A2 | P05177 | 3/20 | 0.40 |
| ▸ | CYP2C19 | P33261 | 3/20 | 0.40 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.40 |
| ▸ | HPGD | P15428 | 2/20 | 0.40 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.40 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.40 |
| ▸ | KMT2A | Q03164 | 5/20 | 0.40 |
| ▸ | MEN1 | O00255 | 4/20 | 0.40 |
| ▸ | CYP2C9 | P11712 | 2/20 | 0.40 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.40 |
| ▸ | MAPT | P10636 | 1/20 | 0.40 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.39 |
| ▸ | ESR1 | P03372 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9966776 | 0.84 | NPC1 (0.50) | POLBL3MBTL1CYP1A2CYP2C19ALDH1A1 | |
| SCHEMBL30758589 | 0.81 | KMT2A (0.57) | POLBL3MBTL1CA12CA1CA2 | |
| SCHEMBL29168850 | 0.81 | KMT2A (0.57) | POLBL3MBTL1CA12CA1CA2 | |
| SCHEMBL3404909 | 0.80 | ESR1 (0.59) | POLBAPAF1CA12CA1CA2 | |
| SCHEMBL29355675 | 0.80 | ESR1 (0.59) | POLBAPAF1CA12CA1CA2 | |
| SCHEMBL30720985 | 0.80 | ESR1 (0.59) | POLBAPAF1CA12CA1CA2 | |
| SCHEMBL9966800 | 0.80 | POLB (0.51) | POLBAPAF1CA12CA1CA2 | |
| SCHEMBL9966873 | 0.77 | POLB (0.56) | POLBAPAF1L3MBTL1CA12CA1 | |
| SCHEMBL3408128 | 0.76 | CYP2D6 (0.57) | POLBAPAF1L3MBTL1CA12CA1 | |
| SCHEMBL29353556 | 0.76 | CYP2D6 (0.57) | POLBAPAF1L3MBTL1CA12CA1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8323357-B2 | Fluorine-substituted perylenes for colour filters in LCDS | LANXESS DEUTSCHLAND GMBH (DE) | 2012-12-04 | — | — | US | disclosed |
| US-8323357-B2 | Fluorine-substituted perylenes for colour filters in LCDS | LANXESS DEUTSCHLAND GMBH (DE) | 2012-12-04 | — | — | US | disclosed |
| EP-2246394-B1 | Fluoride-substituted perylenes for colour filters in LCD | LANXESS DEUTSCHLAND GMBH (DE) | 2012-06-20 | — | — | EP | disclosed |
| EP-2246350-A1 | Fluoride-substituted perylenes for colour filters in LCD | LANXESS Deutschland GmbH (DE) | 2010-11-03 | — | — | EP | disclosed |
| EP-2246394-A1 | Fluoride-substituted perylenes for colour filters in LCD | LANXESS Deutschland GmbH (DE) | 2010-11-03 | — | — | EP | disclosed |
| US-20100264382-A1 | FLUORINE-SUBSTITUTED PERYLENES FOR COLOUR FILTERS IN LCDS | LANXESS DEUTSCHLAND GMBH (DE) | 2010-10-21 | — | — | US | disclosed |
| US-20100264382-A1 | FLUORINE-SUBSTITUTED PERYLENES FOR COLOUR FILTERS IN LCDS | LANXESS DEUTSCHLAND GMBH (DE) | 2010-10-21 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100264382-A1 | FLUORINE-SUBSTITUTED PERYLENES FOR COLOUR FILTERS IN LCDS | NRAS, GSDMD, HRAS | POLB 3289/4885APAF1 1520/4885L3MBTL1 1175/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.